Active Ingredient History
The DPT vaccine or DTP vaccine is a class of combination vaccines against three infectious diseases in humans: diphtheria, pertussis, and tetanus. The vaccine components include diphtheria and tetanus toxoids and either killed whole cells of the bacterium that causes pertussis or pertussis antigens. The whole cells or antigens will be depicted as either "DTwP" or "DTaP", where the lower-case "w" indicates whole-cell inactivated pertussis and the lower-case "a" stands for “acellular”. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
BCG Vaccine (Phase 4)
Diphtheria (Phase 4)
Haemophilus influenzae type b (Phase 4)
Hepatitis A (Phase 3)
Hepatitis A virus (Phase 4)
Hepatitis B (Phase 3)
Hypoxia (Phase 3)
Immunity (Phase 4)
Immunization (Phase 3)
Influenza, Human (Phase 2)
Malaria (Phase 3)
Malaria Vaccines (Phase 3)
Meningococcal Infections (Phase 3)
Neisseria meningitidis (Phase 4)
Papillomavirus Infections (Phase 3)
Pertussis Vaccine (Phase 4)
Pneumonia, Staphylococcal (Phase 3)
Poliomyelitis (Phase 4)
Premature Birth (Phase 3)
Rotavirus Infections (Phase 3)
Streptococcal Infections (Phase 4)
Tetanus (Phase 4)
Vaccines (Phase 4)
Whooping Cough (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue